References
1 [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. Zhonghua Liu Xing Bing Xue Za Zhi 2020; 41 : 145–51.
2 WHO. Coronavirus disease (COVID-19) Situation Report – 107.World Heal Organ 2020; 2019 : 2633.
3 Surveillances V. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi 2020; 41 : 145–51.
4. Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395: 1054–62.
5. Grasselli G, Zangrillo A, Zanella A, et al. Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy. JAMA 2020; published online April. DOI:10.1001/jama.2020.5394.
6. Richardson S, Hirsch JS, Narasimhan M, et al. Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA 2020; published online April. DOI:10.1001/jama.2020.6775.
7. Yan Y, Yang Y, Wang F, et al. Clinical characteristics and outcomes of patients with severe covid-19 with diabetes. BMJ open diabetes Res care 2020; 8. DOI:10.1136/bmjdrc-2020-001343.
8. Yu Y, Xu D, Fu S, et al. Patients with COVID-19 in 19 ICUs in Wuhan, China: a cross-sectional study. Crit Care 2020; 24: 219.
9. Chen T, Wu D, Chen H, et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ 2020; 368. DOI:10.1136/bmj.m1091.
10. The Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators. Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome. JAMA. 2009;(302)
11. Noah M.A., Peek G.J., Finney S.J. Referral to an Extracorporeal Membrane Oxygenation Center and Mortality Among Patients With Severe 2009 Influenza A(H1N1) JAMA. 2011;306:1659–1668.
12. Alshahrani M.S., Sindi A., Alshamsi F. Extracorporeal membrane oxygenation for severe Middle East respiratory syndrome coronavirus. Ann Intensive Care. 2018;8:3
13. Henry BM. COVID-19, ECMO, and lymphopenia: a word of caution. Lancet Respir Med 2020; 8: e24.
14. World Health Organization. WHO Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Who 2020; 2019: 12.
15. Stang A: Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 2010, 25: 603-605.
16. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
17. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327: 557–560.
18. Zhou, Ning and Wang, Luyun and Jiang, Jiangang and Cheng, Peng and Cui, Guanglin and Wang, Feng and Guan, Zhimin and Zhang, Panpan and Li, Shengqing and Wen Wang, Dao, Application of ECMO Successfully Treated Critically Ill COVID-19 Patients (4/1/2020). Available at SSRN: https://ssrn.com/abstract=3569889
19. Zhang G, Hu C, Luo L, et al. Clinical Features and Treatment of 221 Patients with COVID-19 in Wuhan, China. SSRN Electron J 2020. DOI:10.2139/ssrn.3546095.
20. Takeda S. Nationwide system to centralize decisions around ECMO use for severe COVID-19 pneumonia in Japan. Acute Med Surg 2020; 4: 20–1.
21. Jacobs JP, Stammers AH, St Louis J, et al. Extracorporeal Membrane Oxygenation in the Treatment of Severe Pulmonary and Cardiac Compromise in COVID-19: Experience with 32 patients. ASAIO J 2020. DOI:10.1097/MAT.0000000000001185.
22. Yang X, Yu Y, Xu J, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med 2020; 2600: 1–7.
23. Ruan Q, Yang K, Wang W, Jiang L, Song J. Correction to: Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China (Intensive Care Medicine, (2020), 10.1007/s00134-020-05991-x). Intensive Care Med 2020. DOI:10.1007/s00134-020-06028-z.
24. Li X, Guo Z, Li B, et al. Extracorporeal Membrane Oxygenation for Coronavirus Disease 2019 in Shanghai, China. ASAIO J 2020; : 1.
25. Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 2020; 382: 1708–20.
26. Zeng Y, Cai Z, Xianyu Y, Yang BX, Song T, Yan Q. Prognosis when using extracorporeal membrane oxygenation (ECMO) for critically ill COVID-19 patients in China: a retrospective case series. Crit Care 2020; 24: 148.
27. Beyls C, Huette P, Abou-Arab O, Berna P, Mahjoub Y. Extracorporeal membrane oxygenation for COVID-19-associated severe acute respiratory distress syndrome and risk of thrombosis. Br J Anaesth 2020; : 1–3.
28. Osho AA, Moonsamy P, Hibbert KA, et al. Veno-venous Extracorporeal Membrane Oxygenation for Respiratory Failure in COVID-19 Patients: Early Experience From a Major Academic Medical Center in North America. Ann Surg 2020; : 440–53.
29. Haye G, Fourdrain A, Abou-Arab O, Berna P, Mahjoub Y. COVID-19 outbreak in France: Setup and activities of a mobile Extra Corporeal Membrane Oxygenation (ECMO) team during the first 3 weeks. J Cardiothorac Vasc Anesth 2020; 000: 8–10.
30. Ñamendys-Silva SA. ECMO for ARDS due to COVID-19. Heart Lung. 2020 Mar 26:S0147-9563(20)30100-X. doi: 10.1016/j.hrtlng.2020.03.012. Epub ahead of print.
31. Henry BM, Lippi G. Poor survival with extracorporeal membrane oxygenation in acute respiratory distress syndrome (ARDS) due to coronavirus disease 2019 (COVID-19): Pooled analysis of early reports. J Crit Care. 2020 Apr 1;58:27-28.
32. Barbaro RP, Odetola FO, Kidwell KM, Paden ML, Bartlett RH, Davis MM, Annich GM. Association of hospital-level volume of extracorporeal membrane oxygenation cases and mortality: analysis of the Extracorporeal Life Support Organization Registry. Am J Respir Crit Care Med 2015;191:894–901.
33. Force ARDSDT, Ranieri VM, Rubenfeld GD, Thompson BT, Ferguson ND, Caldwell E, Fan E, Camporota L, Slutsky AS. Acute respiratory distress syndrome: the Berlin definition. JAMA. 2012.
34. Gattinoni, L., Chiumello, D. & Rossi, S. COVID-19 pneumonia: ARDS or not? 2020. Crit Care 24, 154 .
35. Yin S, Huang M, Li D, Tang N. Difference of coagulation features between severe pneumonia induced by SARS-CoV2 and non-SARS-CoV2. J Thromb Thrombolysis. 2020. ahead of print
36. Fina D, Matteucci M, Jiritano F, Meani P, Lo Coco V, Kowalewski M, Maessen J, Guazzi M, Ballotta A, Ranucci M, Lorusso R. Extracorporeal membrane oxygenation without therapeutic anticoagulation in adults: a systematic review of the current literature. Int J Artif Organs. 2020:391398820904372. ahead of print.
37. ELSO COVID-19 interim guidelines. ELSO, 2020 (Available from www.elso.org)
38. Munshi L, Walkey A, Goligher E, Pham T, Uleryk EM, Fan E. Venovenous extracorporeal membrane oxygenation for acute respiratory distress syndrome: a systematic review and meta-analysis. Lancet Respir Med. 2019;7(2):163‐172.
39. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, HLH Across Specialty Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020 Mar 28; 395(10229):1033-1034.
40. Abrams D, Ferguson ND, Brochard L, Fan E, Mercat A, Combes A, Pellegrino V, Schmidt M, Slutsky AS, Brodie D. ECMO for ARDS: from salvage to standard of care? Lancet Respir Med. 2019 Feb; 7(2):108-110.